BioCentury
ARTICLE | Financial News

Karyopharm proposes IPO

October 7, 2013 7:00 AM UTC

Karyopharm Therapeutics Inc., Natick, Mass. Business: Cancer, Inflammation Date announced: 10/4/13 Type: IPO To be raised: Up to $80 million Shares: TBD Price: TBD Underwriters: BofA Merrill Lynch; Le...